electroCore, Inc. Share Price & Technical Analysis
ECOR · $6.67 (+11.35%)
Healthcare / Medical Devices
$6.67
+11.35%
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic …
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
2% return in May, -17% avg return in past 3 year May month.
53% return in 2026, 44% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 49% | 13% | -18% | 7% | 2% | – | – | – | – | – | – | – | 53% |
| 25 | 2% | -4% | -59% | 10% | -32% | 6% | 30% | -22% | -6% | 2% | 2% | -12% | -81% |
| 24 | 31% | -7% | -11% | 0% | 2% | 2% | -3% | 2% | 18% | 61% | 6% | 34% | 133% |
| 23 | 37% | -33% | 62% | 11% | -20% | 0% | -8% | 24% | 7% | 2% | -10% | 7% | 80% |
| 22 | 13% | -14% | -1% | -28% | 6% | 13% | 15% | -7% | -22% | -20% | 28% | -25% | -42% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Uptrend
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$56.33M
P/E ratio
—
52W high
$8.64
52W low
$4.16
Volume
1,29,747
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is electroCore, Inc. share price today?
- electroCore, Inc. (ECOR) last traded around $6.67 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ECOR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ECOR. Download the app for real-time alerts.
- How can I analyze electroCore, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.